Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease

Endocrinol Metab Clin North Am. 2022 Mar;51(1):187-204. doi: 10.1016/j.ecl.2021.11.012. Epub 2022 Feb 8.

Abstract

Sarcopenia is characterized by loss of muscle strength and physical ability because of aging and/or chronic disease. Supplemental testosterone and other androgenic-anabolic steroids have been investigated as countermeasures to ameliorate the negative consequences of sarcopenia; these trials show dose-related improvements in lean body mass, maximal voluntary strength, stair climbing power, aerobic capacity, hemoglobin, and self-reported function, but less consistent improvements in walking speed. Randomized clinical trials with large cohorts and patient-important outcome measures are needed to determine long-term efficacy and safety of testosterone treatment in improving physical function and reducing physical disability, falls, and fractures in older adults with sarcopenia.

Keywords: Androgens; Body composition; Muscle strength; Physical function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Aged
  • Aging
  • Body Composition / physiology
  • Chronic Disease
  • Double-Blind Method
  • Humans
  • Muscle, Skeletal / physiology
  • Sarcopenia* / drug therapy
  • Sarcopenia* / etiology
  • Testosterone* / adverse effects

Substances

  • Testosterone